Media Summary: The FDA granted emergency use authorization for the treatment back in November. WebMD's Chief Medical Officer, John Whyte, MD, speaks with George Yancopoulos, MD, PhD, CNBC's Meg Tirrell joins 'Closing Bell' to report details on the
Regeneron Ceo On How Antibody - Detailed Analysis & Overview
The FDA granted emergency use authorization for the treatment back in November. WebMD's Chief Medical Officer, John Whyte, MD, speaks with George Yancopoulos, MD, PhD, CNBC's Meg Tirrell joins 'Closing Bell' to report details on the
